menu
    • menu

    Company profile for Mylan Group

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The Mylan Group is able to provide custom formulated inks dedicated to empowering our customers. Over the years, we have worked with 50+ countries and brand-new startups. We help ambitious businesses like yours generate more profits by building digital inkjet printing systems for specialty applications, connecting with customers, and growing overall sales. We have experience working with large and small businesses and are r...
    The Mylan Group is able to provide custom formulated inks dedicated to empowering our customers. Over the years, we have worked with 50+ countries and brand-new startups. We help ambitious businesses like yours generate more profits by building digital inkjet printing systems for specialty applications, connecting with customers, and growing overall sales. We have experience working with large and small businesses and are ready to develop a targeted strategy and plan that’s just right for you. Give us a call.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mylan GroupVietNam Flag
    Country
    Country
    Vietnam
    Address
    Address
    Longduc Industrial Park Travinh City, Travinh Province
    Telephone
    Telephone
    +84 -294-3846-997
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://mylangroup.com/about-us/
    Linkedin
    Linkedin
    https://www.linkedin.com/in/mylan-group-8b00ab1a6/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Cosmoprof WW Bologna

    Cosmoprof WW Bologna

    Not Confirmed

    envelop Contact Supplier

    Cosmoprof WW Bologna

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mylan’s Generics Linagliptin Receives Approval in US
    Mylan’s Generics Linagliptin Receives Approval in US

    03 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208431

    FDA
    03 Nov 2025
    Share Share
    Mylan’s Generics Amphotericin B Receives US FDA Approval
    Mylan’s Generics Amphotericin B Receives US FDA Approval

    30 Jun 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212967

    FDA
    30 Jun 2025
    Share Share
    Mylan Gmbh`s Biologic Ogivri Receives Suppl Approval in US
    Mylan Gmbh`s Biologic Ogivri Receives Suppl Approval in US

    13 Nov 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761074

    FDA
    13 Nov 2024
    Share Share
    Department of Justice No Longer Considers Mylan Subject Of Antitrust
    Department of Justice No Longer Considers Mylan Subject Of Antitrust

    02 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/us-department-of-justice-informs-viatris-that-it-no-longer-considers-mylan-a-subject-of-generic-drug-industry-antitrust-investigation-302187520.html

    PR NEWSWIRE
    02 Jul 2024
    Share Share
    Mylan's Generic Epoprostenol Sodium Receives Approval in US
    Mylan's Generic Epoprostenol Sodium Receives Approval in US

    12 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213913

    FDA
    12 Jun 2024
    Share Share
    Viatris leans in on brand drug portfolio for future growth
    Viatris leans in on brand drug portfolio for future growth

    08 May 2023

    // Beth Snyder Bulik ENDPTS

    https://endpts.com/viatris-leans-in-on-brand-drug-portfolio-for-future-growth/

    Beth Snyder Bulik ENDPTS
    08 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search